MET and cancer: Further, to better understand the mechanisms how miR-133b regulates cellular phenotypes of osteosarcoma cells, we first measured the expression of BCL2L2, MCL-1, IGF1R and MET, which are identified as the target genes of miR-133b in several cancers [12], [36], [37].